Atovaquone/proguanil resistance in Africa: a case report

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Atovaquone/proguanil resistance in Africa: a case report. / David, Kim P; Alifrangis, Michael; Salanti, Ali; Vestergaard, Lasse S; Rønn, Anita; Bygbjerg, I B.

I: Scandinavian Journal of Infectious Diseases, Bind 35, Nr. 11-12, 2003, s. 897-8.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

David, KP, Alifrangis, M, Salanti, A, Vestergaard, LS, Rønn, A & Bygbjerg, IB 2003, 'Atovaquone/proguanil resistance in Africa: a case report', Scandinavian Journal of Infectious Diseases, bind 35, nr. 11-12, s. 897-8.

APA

David, K. P., Alifrangis, M., Salanti, A., Vestergaard, L. S., Rønn, A., & Bygbjerg, I. B. (2003). Atovaquone/proguanil resistance in Africa: a case report. Scandinavian Journal of Infectious Diseases, 35(11-12), 897-8.

Vancouver

David KP, Alifrangis M, Salanti A, Vestergaard LS, Rønn A, Bygbjerg IB. Atovaquone/proguanil resistance in Africa: a case report. Scandinavian Journal of Infectious Diseases. 2003;35(11-12):897-8.

Author

David, Kim P ; Alifrangis, Michael ; Salanti, Ali ; Vestergaard, Lasse S ; Rønn, Anita ; Bygbjerg, I B. / Atovaquone/proguanil resistance in Africa: a case report. I: Scandinavian Journal of Infectious Diseases. 2003 ; Bind 35, Nr. 11-12. s. 897-8.

Bibtex

@article{48b6b2d01a4611df8ed1000ea68e967b,
title = "Atovaquone/proguanil resistance in Africa: a case report",
abstract = "The Atovaquone/proguanil combination has quickly been established as an effective chemoprophylaxis for travellers to areas with chloroquineresistant Plasmodium falciparum malaria. We describe the molecular cause of the first reported case of primary Atovaquone/proguanil resistance observed in our department in a Plasmodium falciparum infected traveller returning from West Africa, and link our findings to other reports of resistance.",
author = "David, {Kim P} and Michael Alifrangis and Ali Salanti and Vestergaard, {Lasse S} and Anita R{\o}nn and Bygbjerg, {I B}",
note = "Keywords: Adult; Africa; Animals; Atovaquone; Bacterial Proteins; Chloroguanide; Cytochrome b Group; Denmark; Drug Resistance, Multiple; Drug Therapy, Combination; Ferritins; Humans; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Mutation; Naphthoquinones; Pharmacogenetics; Plasmodium falciparum; Polymerase Chain Reaction; Risk Assessment; Travel; Treatment Failure",
year = "2003",
language = "English",
volume = "35",
pages = "897--8",
journal = "Infectious Diseases",
issn = "2374-4235",
publisher = "Taylor & Francis",
number = "11-12",

}

RIS

TY - JOUR

T1 - Atovaquone/proguanil resistance in Africa: a case report

AU - David, Kim P

AU - Alifrangis, Michael

AU - Salanti, Ali

AU - Vestergaard, Lasse S

AU - Rønn, Anita

AU - Bygbjerg, I B

N1 - Keywords: Adult; Africa; Animals; Atovaquone; Bacterial Proteins; Chloroguanide; Cytochrome b Group; Denmark; Drug Resistance, Multiple; Drug Therapy, Combination; Ferritins; Humans; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Mutation; Naphthoquinones; Pharmacogenetics; Plasmodium falciparum; Polymerase Chain Reaction; Risk Assessment; Travel; Treatment Failure

PY - 2003

Y1 - 2003

N2 - The Atovaquone/proguanil combination has quickly been established as an effective chemoprophylaxis for travellers to areas with chloroquineresistant Plasmodium falciparum malaria. We describe the molecular cause of the first reported case of primary Atovaquone/proguanil resistance observed in our department in a Plasmodium falciparum infected traveller returning from West Africa, and link our findings to other reports of resistance.

AB - The Atovaquone/proguanil combination has quickly been established as an effective chemoprophylaxis for travellers to areas with chloroquineresistant Plasmodium falciparum malaria. We describe the molecular cause of the first reported case of primary Atovaquone/proguanil resistance observed in our department in a Plasmodium falciparum infected traveller returning from West Africa, and link our findings to other reports of resistance.

M3 - Journal article

C2 - 14723376

VL - 35

SP - 897

EP - 898

JO - Infectious Diseases

JF - Infectious Diseases

SN - 2374-4235

IS - 11-12

ER -

ID: 17656922